Free ACCA & CIMA online courses from OpenTuition
Free Notes, Lectures, Tests and Forums for ACCA and CIMA exams
December 2023 - June 2024 exams: Get your discount code >>
January 2, 2022 at 5:08 am
Shouldn’t we first offset the impairment against the revaluation surplus (as taught in the previous chapter) and only take any excess to the p/l?
July 11, 2021 at 1:23 pm
Sir, i thought we are using 13,900 as carrying amount and not 15,400 which is the fair value
Please do reply.
Thank you Sir
September 8, 2021 at 1:07 pm
Watch Previous lecture, revaluation model PPE are revalued to fair value at the date the PPE is classified as held for sale. An gain goes through OCI. This fair value becomes the carrying amount that is then compared to fair value less cost to sell. Any difference is impairment through profit or loss.
December 13, 2021 at 4:00 pm
August 24, 2022 at 8:54 pm
it means the Fair value less cost sales will always be used as against CV. because that will always be lower than CV
January 19, 2022 at 10:29 am
We assumption that this example, IFRS 5 uses Revaluation model. If IFRS 5 uses cost model, so use 13.9 as Initial cost of IFRS 5.
March 4, 2023 at 4:59 pm
But then I do not understand the phrase „ Non-current asset held for sale is valued at the lower of the carrying value and fair value less costs to sell.“ which comes from the notes…
July 17, 2023 at 8:14 pm
As this is following the revaluation model, the notes specify that the asset should be immediately revalued before being classified as HFS. Therefore, the 15,400 is now considered as the new carrying value as 13,900 resulted from a previous revaluation that currently did not apply to the asset anymore. Please correct if i am wrong
June 30, 2021 at 9:46 am
Sir, the value of NCA HFS is lower of carrying value and fair value less cost to sell….
I thought the carrying value here is 13,900.
Expecting your answer and clarification.
You must be logged in to post a comment.